APP and Alzheimer disease: The first one used intraventricular 192-IgG Saporin infusion to lesion the NBM, which was stimulated thereafter13, while the others used transgenic mouse and rat models of AD, overexpressing Amyloid-β precursor and Presenilin1 protein (APP/PS1)14,29.